Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Third Harmonic Bio Inc is a clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation.
| Last: | $5.38 |
|---|---|
| Change Percent: | -0.56% |
| Open: | $5.41 |
| Close: | $5.38 |
| High: | $5.43 |
| Low: | $5.345 |
| Volume: | 1,417,958 |
| Last Trade Date Time: | 07/30/2025 03:40:41 pm |
| Market Cap: | $242,787,548 |
|---|---|
| Float: | 21,345,447 |
| Insiders Ownership: | N/A |
| Institutions: | 7 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.thirdharmonicbio.com |
| Country: | US |
| City: | Cambridge |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Third Harmonic Bio Inc. (NASDAQ: THRD).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.